Advancements in MAFLD Modeling with Human Cell and Organoid Models

Area of Science:

• Hepatology
• Cell Biology
• Disease Modeling

Background:

• Metabolic dysfunction associated fatty liver disease (MAFLD) is a widespread liver condition lacking approved treatments.
• The complexity of MAFLD hinders drug development, necessitating better disease understanding.
• In vitro human models are vital for studying MAFLD mechanisms and testing drug efficacy.

Purpose of the Study:

• To review human cell and organoid models for MAFLD.
• To discuss the application of these models in understanding MAFLD pathogenesis.
• To highlight their role in preclinical drug testing for MAFLD.

Main Methods:

• Review of literature on human cell lines and organoids for MAFLD modeling.
• Analysis of patient-derived primary cells and immortalized cell lines.
• Examination of various cell culture platforms used in MAFLD research.

Main Results:

• Patient-derived cells and established cell lines model key MAFLD cell types.
• Organoid models and advanced culture systems recapitulate MAFLD pathophysiology.
• These models offer insights into disease drivers and human-specific responses.

Conclusions:

• Human cell and organoid models are essential tools for MAFLD research.
• These models facilitate mechanistic studies and drug discovery for MAFLD.
• Further development and application of these models are critical for advancing MAFLD therapeutics.